PortfoliosLab logoPortfoliosLab logo
LCFY vs. VOR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LCFY vs. VOR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Locafy Ltd (LCFY) and Vor Biopharma Inc. (VOR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LCFY achieves a -20.71% return, which is significantly lower than VOR's 61.70% return.


LCFY

1D
-5.53%
1M
-28.16%
6M
-24.49%
YTD
-20.71%
1Y
-53.56%
3Y*
-31.11%
5Y*
10Y*
ALL TIME*
-54.27%

VOR

1D
-2.98%
1M
2.72%
6M
62.69%
YTD
61.70%
1Y
-49.64%
3Y*
-30.65%
5Y*
-39.00%
10Y*
ALL TIME*
-48.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$34.36K$31.88K$48.29K
$17.33M$24.46M$20.23M

LCFY vs. VOR - Yearly Performance Comparison


2026 (YTD)2025202420232022
LCFY
Locafy Ltd
-20.71%-59.24%-24.30%53.82%-91.17%
VOR
Vor Biopharma Inc.
61.70%-41.08%-50.67%-66.17%-10.86%

Correlation

The correlation between LCFY and VOR is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.09

Correlation (3Y)
Balances recent behavior with more history.

0.06

Correlation (All Time)
Calculated using the full available price history since Mar 25, 2022

0.06

Fundamentals

Market Cap

LCFY:

$3.99M

VOR:

$1.15B

EPS

LCFY:

-A$2.87

VOR:

-$44.48

Total Revenue (TTM)

LCFY:

A$6.15M

VOR:

$0.00

Gross Profit (TTM)

LCFY:

A$2.48M

VOR:

-$23.00K

EBITDA (TTM)

LCFY:

-A$3.39M

VOR:

-$1.13B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Locafy Ltd

Vor Biopharma Inc.

Return for Risk

LCFY vs. VOR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LCFY
LCFY Risk / Return Rank: 1717
Overall Rank
LCFY Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
LCFY Sortino Ratio Rank: 1818
Sortino Ratio Rank
LCFY Omega Ratio Rank: 2020
Omega Ratio Rank
LCFY Calmar Ratio Rank: 1313
Calmar Ratio Rank
LCFY Martin Ratio Rank: 1313
Martin Ratio Rank

VOR
VOR Risk / Return Rank: 2929
Overall Rank
VOR Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
VOR Sortino Ratio Rank: 3434
Sortino Ratio Rank
VOR Omega Ratio Rank: 3434
Omega Ratio Rank
VOR Calmar Ratio Rank: 2323
Calmar Ratio Rank
VOR Martin Ratio Rank: 2929
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LCFY vs. VOR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Locafy Ltd (LCFY) and Vor Biopharma Inc. (VOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LCFYVORDifference
Sharpe ratioReturn per unit of total volatility

-0.15

Sortino ratioReturn per unit of downside risk

-0.70

Omega ratioGain probability vs. loss probability

0.93

1.01

-0.08

Calmar ratioReturn relative to maximum drawdown

-0.78

-0.57

-0.21

Martin ratioReturn relative to average drawdown

-1.25

-0.79

-0.46

LCFY vs. VOR - Sharpe Ratio Comparison

The current LCFY Sharpe Ratio is -0.57, which is lower than the VOR Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of LCFY and VOR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LCFY vs. VOR - Drawdown Comparison

The maximum LCFY drawdown since its inception was -96.68%, roughly equal to the maximum VOR drawdown of -99.72%. Use the drawdown chart below to compare losses from any high point for LCFY and VOR.


Loading charts...

Drawdown Indicators


LCFYVORDifference

Max Drawdown

Largest peak-to-trough decline

-96.68%

-99.72%

+3.04%

Max Drawdown (1Y)

Largest decline over 1 year

-69.67%

-85.92%

+16.25%

Max Drawdown (3Y)

Largest decline over 3 years

-77.36%

-94.85%

+17.49%

Max Drawdown (5Y)

Largest decline over 5 years

-99.16%

Current Drawdown

Current decline from peak

-96.68%

-98.04%

+1.36%

Average Drawdown

Average peak-to-trough decline

-88.97%

-88.92%

-0.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

43.57%

61.89%

-18.32%

Volatility

LCFY vs. VOR - Volatility Comparison

The current volatility for Locafy Ltd (LCFY) is 18.06%, while Vor Biopharma Inc. (VOR) has a volatility of 24.91%. This indicates that LCFY experiences smaller price fluctuations and is considered to be less risky than VOR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LCFYVORDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.06%

24.91%

-6.85%

Volatility (6M)

Calculated over the trailing 6-month period

50.23%

57.54%

-7.31%

Volatility (1Y)

Calculated over the trailing 1-year period

96.46%

116.05%

-19.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

173.12%

116.61%

+56.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

173.12%

116.15%

+56.97%

Dividends

LCFY vs. VOR - Dividend Comparison

Neither LCFY nor VOR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

LCFY vs. VOR - Financials Comparison

This section allows you to compare key financial metrics between Locafy Ltd and Vor Biopharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


LCFY and VOR have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VOR has higher volatility (24.91%) compared to LCFY (18.06%). In terms of maximum drawdown, LCFY dropped -96.68% vs VOR's -99.72%.

VOR currently has the higher Sharpe Ratio (-0.42 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LCFY and VOR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer